...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Reports of Exempt Distribution
1
Feb 04, 2023 09:01AM
2
Feb 22, 2023 09:43AM
1
Feb 24, 2023 10:39AM

Toinv Good Point on the convertible note being a vehicle to a future eqyuity position , although a very small finance some in Germany has taken a liking to Zenith ,  I am wondering if the German buy is connected to CD ventures (ie  Christopher Boehringer  aka   BP Boehinger Ingelheim ??

Share
New Message
Please login to post a reply